Anti SARS-CoV-2 gammaglobuli

计划入组 30 人

ithium Carbonate-COVID-19- mild and moderate -Exploratory / Phase II

计划入组 192 人

MAMBISA Study

计划入组 88 人

Broadly Protective Betacoronavirus Vaccine

Emergex's T Cell Vaccine Selected for NIH's Project NextGen Clinical Trials

Mosaic-8b Nanoparticle Vaccine Shows Promise Against Sarbecovirus Variants